Evolve Global Healthcare Enhanced Yield Fund Trust Units USD UnhedgedEvolve Global Healthcare Enhanced Yield Fund Trust Units USD UnhedgedEvolve Global Healthcare Enhanced Yield Fund Trust Units USD Unhedged

Evolve Global Healthcare Enhanced Yield Fund Trust Units USD Unhedged

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪11.33 M‬USD
Fund flows (1Y)
‪−5.79 M‬USD
Dividend yield (indicated)
Discount/Premium to NAV
−0.1%
Shares outstanding
‪601.04 K‬
Expense ratio
0.72%

About Evolve Global Healthcare Enhanced Yield Fund Trust Units USD Unhedged


Issuer
Evolve Funds Group, Inc.
Brand
Evolve
Inception date
Nov 27, 2019
Structure
Canadian Mutual Fund Trust (ON)
Index tracked
Solactive Global Healthcare 20 Index - Benchmark TR Net
Management style
Passive
Dividend treatment
Distributes
Primary advisor
Evolve Funds Group, Inc.
ISIN
CA30051T3091
The fund is a passively managed ETF that provides exposure to 20 of the largest healthcare stocks in developed countries. The fund holds companies identified as Health Technology using FactSets Revere Business Industry Classification System. At any time, the fund manager can write covered call options at its discretion on not more than 33% of its securities, depending on market volatility and other factors. The index is and reviewed quarterly, assigning equal weights for each eligible security.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Broad-based
Strategy
Buy-write
Geography
Global
Weighting scheme
Fixed
Selection criteria
Fixed

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of October 1, 2025
Exposure type
Stocks
Health Technology
Stocks100.70%
Health Technology100.00%
Bonds, Cash & Other−0.70%
Cash−0.09%
Rights & Warrants−0.61%
Stock breakdown by region
69%30%
North America69.32%
Europe30.68%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows



Frequently Asked Questions


LIFE.U top holdings are AbbVie, Inc. and Thermo Fisher Scientific Inc., occupying 6.15% and 6.02% of the portfolio correspondingly.
LIFE.U assets under management is ‪11.33 M‬ USD. It's risen 0.76% over the last month.
LIFE.U fund flows account for ‪−7.88 M‬ USD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, LIFE.U doesn't pay dividends to its holders.
LIFE.U shares are issued by Evolve Funds Group, Inc. under the brand Evolve. The ETF was launched on Nov 27, 2019, and its management style is Passive.
LIFE.U expense ratio is 0.72% meaning you'd have to pay 0.72% of your investment to help manage the fund.
LIFE.U follows the Solactive Global Healthcare 20 Index - Benchmark TR Net. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
LIFE.U invests in stocks.
LIFE.U price has risen by 1.00% over the last month, and its yearly performance shows a −10.88% decrease. See more dynamics on LIFE.U price chart.
NAV returns, another gauge of an ETF dynamics, showed a −3.33% decrease in three-month performance and has decreased by −2.75% in a year.
LIFE.U trades at a premium (0.13%) meaning the ETF is trading at a higher price than the calculated NAV.